INDV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Indivior Pharmaceuticals, Inc (INDV) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows strong financial performance, a bullish technical setup, and a favorable options sentiment, making it a solid choice for long-term growth.
The stock is in a bullish trend with SMA_5 > SMA_20 > SMA_200. MACD is positive at 0.282, indicating bullish momentum. RSI at 62.46 is neutral, and the stock is trading near its resistance level of 33.413, with support at 32.04.
Strong financial performance in Q3 2025 with revenue up 2.28% YoY, net income up 90.91% YoY, and EPS up 94.12% YoY. The bullish technical indicators and favorable options sentiment further support the stock's positive outlook.
Gross margin dropped by 6.28% YoY in Q3 2025, which could indicate some cost pressures. Additionally, there is no recent news or major insider/hedge fund activity to act as a catalyst.
In Q3 2025, revenue increased to $314M (+2.28% YoY), net income surged to $42M (+90.91% YoY), and EPS rose to $0.33 (+94.12% YoY). However, gross margin dropped to 73.57% (-6.28% YoY).
No recent analyst ratings or price target changes are available for INDV.
